Skip to main content
editorial
. 2013 Mar 6;40(6):819–823. doi: 10.1007/s00259-013-2374-2

Fig. 2.

Fig. 2

PET images in the same patient using the 68Ga-labelled PSMA inhibitor Glu-NH-CO-NH-Lys(Ahx)-HBED-CC (a) and 18F-fluoroethylcholine (b). The scan with the PSMA ligand shows significantly more lesions than the fluoroethylcholine scan in which only one metastasis is seen